Flagyl Er is a drug owned by Pfizer Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 15, 2017. Details of Flagyl Er's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6103262 | Modified-release metronidazole compositions and methods for making and using same |
Aug, 2017
(7 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Flagyl Er is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Flagyl Er's family patents as well as insights into ongoing legal events on those patents.
Flagyl Er's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Flagyl Er's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 15, 2017 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Flagyl Er Generic API suppliers:
Metronidazole is the generic name for the brand Flagyl Er. 38 different companies have already filed for the generic of Flagyl Er, with Alembic having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Flagyl Er's generic
Alternative Brands for Flagyl Er
Flagyl Er which is used for treating bacterial vaginosis., has several other brand drugs in the same treatment category and using the same active ingredient (Metronidazole). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | Treatment Area | ||
|---|---|---|---|---|
| Bausch |
| |||
| Padagis Us |
| |||
Apart from drugs working in same treatment category, there are also some brand drugs where treatment area is different, but the active ingredient used is same i.e. Metronidazole. Given below is the list of those drugs and companies owning them.
| Drug Owner | Drug Name | |
|---|---|---|
| Chemo Research Sl |
| |
| Galderma Labs Lp |
| |
| Labs Juvise |
| |
| Saptalis Pharms |
| |
| Teva Pharms |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Metronidazole, Flagyl Er's active ingredient. Check the complete list of approved generic manufacturers for Flagyl Er
About Flagyl Er
Flagyl Er is a drug owned by Pfizer Inc. It is used for treating bacterial vaginosis. Flagyl Er uses Metronidazole as an active ingredient. Flagyl Er was launched by Pfizer in 1997.
Approval Date:
Flagyl Er was approved by FDA for market use on 26 November, 1997.
Active Ingredient:
Flagyl Er uses Metronidazole as the active ingredient. Check out other Drugs and Companies using Metronidazole ingredient
Treatment:
Flagyl Er is used for treating bacterial vaginosis.
Dosage:
Flagyl Er is available in tablet, extended release form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 750MG | TABLET, EXTENDED RELEASE | Discontinued | ORAL |